Novo CEO pressed by Senate to chop costs of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporate would think about new talks with insurers with regard to the list selling prices of Wegovy and copyright when they pledge to keep the medicines on their own formularies. https://arizonahardnutritionfacts15059.verybigblog.com/30117337/everything-about-healthcare-news